Home › Coronary Artery Disease
Coronary Artery Disease clinical trials recruiting in the U.S.
66 studies for Coronary Artery Disease are recruiting participants at sites across the United States.
Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.
Cities with the most studies
- New York City, NY20 studies
- Dallas, TX16 studies
- Boston, MA16 studies
- Atlanta, GA16 studies
- Minneapolis, MN15 studies
- Jacksonville, FL12 studies
- Cleveland, OH12 studies
- Nashville, TN11 studies
- Durham, NC9 studies
- Columbus, OH9 studies
- Plano, TX9 studies
- Philadelphia, PA9 studies
- Houston, TX8 studies
- Phoenix, AZ8 studies
- Memphis, TN8 studies
- Portland, OR8 studies
- New Rochelle, NY8 studies
- Chicago, IL8 studies
- Los Angeles, CA8 studies
- Louisville, KY8 studies
- Pittsburgh, PA8 studies
- Wichita, KS7 studies
- Camden, NJ7 studies
- Tampa, FL7 studies
- Indianapolis, IN7 studies
- Mountain View, CA6 studies
- Miami, FL6 studies
- Aurora, CO6 studies
- St. Louis, MO6 studies
- Oklahoma City, OK6 studies
- Queens, NY6 studies
- Huntsville, AL6 studies
- Warren, MI6 studies
- The Bronx, NY6 studies
- Buffalo, NY6 studies
- Raleigh, NC6 studies
- Birmingham, AL6 studies
- Cincinnati, OH6 studies
- San Bernardino, CA5 studies
- Little Rock, AR5 studies
By state
- Alabama11 studies
- Arizona14 studies
- Arkansas5 studies
- California24 studies
- Colorado12 studies
- Connecticut8 studies
- District of Columbia4 studies
- Florida25 studies
- Georgia19 studies
- Illinois11 studies
- Indiana13 studies
- Iowa5 studies
- Kansas9 studies
- Kentucky10 studies
- Louisiana4 studies
- Maryland8 studies
- Massachusetts19 studies
- Michigan14 studies
- Minnesota21 studies
- Mississippi6 studies
- Missouri10 studies
- Nebraska7 studies
- New Hampshire3 studies
- New Jersey15 studies
- New Mexico4 studies
- New York22 studies
- North Carolina20 studies
- Ohio20 studies
- Oklahoma7 studies
- Oregon9 studies
- Pennsylvania16 studies
- Rhode Island5 studies
- South Carolina10 studies
- Tennessee14 studies
- Texas26 studies
- Utah5 studies
- Virginia7 studies
- Washington6 studies
- West Virginia7 studies
- Wisconsin7 studies
Recently updated studies
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
Recruiting
Ages 18 to 80 · All sexes · Updated Nov 12, 2026 · NCT07258290The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07479433A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Nov 10, 2026 · NCT07839936A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Recruiting
Ages 18 to 85 · All sexes · Updated Nov 10, 2026 · NCT07286578PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
Recruiting
Ages 18 to 90 · All sexes · Updated Nov 9, 2026 · NCT06445608The Bridging Antiplatelet Therapy With Cangrelor 2 Study
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07225842Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06779630A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 5, 2026 · NCT07521007Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
Recruiting
Ages 55 and older · All sexes · Updated Nov 2, 2026 · NCT07704918Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Recruiting
Ages 18 to 90 · All sexes · Updated Nov 2, 2026 · NCT07296744A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07357675Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
RecruitingObservational study
Ages 18 to 99 · Men · Updated Oct 30, 2026 · NCT05611307Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06909565Lifewise Preventive Video Education in Primary Care
RecruitingHealthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Oct 29, 2026 · NCT06730737Virtue® SAB in the Treatment of Coronary ISR Trial
Recruiting
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT07045194Prevail Global Study
Recruiting
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT06535854Product Surveillance Registry
RecruitingObservational study
All ages · All sexes · Updated Oct 20, 2026 · NCT01524276The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Recruiting
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT05427370Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Oct 15, 2026 · NCT07830719Prevent Cardiac Surgery Associated AKI Trial
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 14, 2026 · NCT06620523Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT07025148ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
Recruiting
Ages 40 and older · Men · Updated Oct 5, 2026 · NCT05879913ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07559903IVUS CHIP UPP Registry
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06625801Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.